Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3813 publications

IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer.

IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer.

Journal: Future oncology (London, England)
Published: October 07, 2025

Lack of Complications of High-Dose Intravitreal Topotecan for Recurrent Retinoblastoma in 81 Consecutive Injections.

Lack of Complications of High-Dose Intravitreal Topotecan for Recurrent Retinoblastoma in 81 Consecutive Injections.

Journal: Retina (Philadelphia, Pa.)
Published: September 15, 2025

An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety.

An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety.

Journal: Radiology. Imaging cancer
Published: August 29, 2025

Transcriptomic Analysis of TDP1-Knockout HEK293A Cells Treated with the TDP1 Inhibitor (Usnic Acid Derivative).

Transcriptomic Analysis of TDP1-Knockout HEK293A Cells Treated with the TDP1 Inhibitor (Usnic Acid Derivative).

Journal: International journal of molecular sciences
Published: August 01, 2025

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Journal: Expert opinion on investigational drugs
Published: July 19, 2025

High-dose intravitreal topotecan (100 mcg/0.1cc) as monotherapy for recurrent/refractory intraocular retinoblastoma in seven eyes.

High-dose intravitreal topotecan (100 mcg/0.1cc) as monotherapy for recurrent/refractory intraocular retinoblastoma in seven eyes.

Journal: Retina (Philadelphia, Pa.)
Published: July 09, 2025

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.

M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.

Journal: International journal of molecular sciences
Published: July 08, 2025

Hypercellular Proinflammatory Microenvironment Inhibits the Etoposide-Induced DNA Damage in Acute Monocytic Leukemia Cells.

Hypercellular Proinflammatory Microenvironment Inhibits the Etoposide-Induced DNA Damage in Acute Monocytic Leukemia Cells.

Journal: Biochemistry. Biokhimiia
Published: June 27, 2025

PyaiVS unifies AI workflows to accelerate ligand discovery and yields ABCG2 inhibitors.

PyaiVS unifies AI workflows to accelerate ligand discovery and yields ABCG2 inhibitors.

Journal: European journal of medicinal chemistry
Published: June 24, 2025

Unveiling the potential of lichen compounds hyaluronic acid conjugates for cervical cancer treatment: a comprehensive in silico analysis.

Unveiling the potential of lichen compounds hyaluronic acid conjugates for cervical cancer treatment: a comprehensive in silico analysis.

Journal: Journal of biomolecular structure & dynamics
Published: June 14, 2025

Non-coding RNAs' pivotal importance in modulation of cancer sensitivity to Topotecan: a systematic review.

Non-coding RNAs' pivotal importance in modulation of cancer sensitivity to Topotecan: a systematic review.

Journal: Medical oncology (Northwood, London, England)
Published: June 13, 2025

Synthesis and investigation of thieno[2,3-b]pyridines that restore activity of topotecan.

Synthesis and investigation of thieno[2,3-b]pyridines that restore activity of topotecan.

Journal: RSC medicinal chemistry
Published: June 06, 2025
Showing 1-12 of 3,813

Last Updated: 10/31/2025